Business Context and Reporting Period
This Form 8-K Current Report was filed by Harvard Bioscience, Inc. on June 13, 2025, covering events occurring on June 10, 2025. The company is incorporated in Delaware and its common stock trades on the NASDAQ Stock Market under the symbol HBIO.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statement data.
Material Changes
The primary material change reported is a corporate governance event:
- Board Departure: Alan Edrick resigned from the Board of Directors, effective June 10, 2025.
- Reason for Departure: The resignation was not the result of any disagreement or matter relating to the Company's operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the disclosure of the director's resignation and the submission of the cover page interactive data file.
Investor Verification Checklist
- Verify the current composition of the Board of Directors following Mr. Edrick's resignation.
- Confirm whether the Board has initiated a search for a replacement director.
- Review recent 10-Q or 10-K filings for the most up-to-date financial performance metrics, as this 8-K does not include them.